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A 16-year-old left-handed male is presented with a history of seizures associated with a fish-like odour and 
behavioural disturbances thought to be related to trimethylaminuria. His seizures were complex-partial (cursive) 
seizures and started at the age of 18 months. They occurred in the context of discrete episodes several times per 
year. The episodes would start with a fish-like odour, followed by seizures occurring in clusters and behavioural 
disturbance consisting of agitation, mixed affective symptoms, auditory hallucinations and delusions. A urinary 
assay of trimethylamine (TMA) was elevated, confirming the diagnosis of trimethylaminuria in this patient. He was 
treated with a choline-restricted diet with resolution of his symptoms. The occurrence of seizures and psychiatric 
disturbance in this patient was thought secondary to his trimethylaminuria due to the temporal relationship of his 
seizures and psychiatric disturbance with the odour and his response to treatment. The possible relationship of 
trimethylaminuria to seizures and to psychiatric disturbance are discussed and a review of the literature presented. 
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INTRODUCTION 
Trimethylaminuria is a disorder of impaired 
N-oxidation of trimethylamine, characterized by 
a fish-like odour. People with this disorder secrete 
the malodorous trimethylamine in their breath, 
sweat, urine, and other body secretions’. Al- 
though seizures’ and behavioural disturbance3 
have been reported in trimethylaminuria pre- 
viously, the seizures have been presumed to be an 
incidental finding and the behavioral disturbance 
secondary to the psychosocial consequences of 
the odour4. Presented here is a case of a young 
boy with trimethylaminuria with seizures and 
behavioral disturbance temporally related to the 
development of the fish odour. 
CASE REPORT 
A 16-year-old left-handed boy presented with a 
history of periodic seizures associated with severe 
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behavioural disturbance. The episodes would last 
between 1 day and 5 weeks (average 15 days), and 
started with a characteristic fish-like odour 
noticed by his family, teachers, and friends, but 
not by the patient himself. This would often be 
associated with a tremor, drooling and a sense of 
elation. His seizures and behavioural disturbance 
would then start within a few hours to 1 day after 
the onset of the odour. The seizures would occur 
in clusters during these episodes. They would 
start with an epigastric sensation, abdominal pain 
and nausea; the right arm would then stiffen, and 
he would then be seen to be staring with lip 
smacking, and confusion. This would be followed 
by running and at times a severe headache. His 
behavioural disturbance had three phases: (1) a 
period of being agitated, aggressive, not sleeping 
with auditory and/or visual hallucinations; (2) tin 
anxious phase with panic symptoms and repeti- 
tive movements of his arms, e.g. chopping; and 
(3) hyperphagia and hypersomnolence. Also of 
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note, were concerns expressed by his teachers and 
mother of a gradual cognitive decline. 
Past history 
His past medical history was remarkable for an 
episode of apparent Sydenham’s chorea at age 8. 
During that time, he had severe chorea over a 
2-month period resolving with haloperidol. At the 
time, he was also diagnosed with mitral valve 
prolapse. His seizures began at age 18 months, 
but initially occurred nocturnally only and were 
felt to be night terrors. His seizure disorder was 
then diagnosed with telemetry at age 6, but he 
had few seizures until the age of 9, shortly after 
his admission for chorea. These were thought 
initially to be due to treatment with haloperidol 
and he was not treated with antiepileptic drugs 
(AEDs) until the age of 11, when he was started 
on carbamazepine. He has no history of drug, 
alcohol or tobacco abuse. 
His past psychiatric history is remarkable for 
his diagnosis with night terrors at age 18 months, 
thought to be likely nocturnal seizures in retros- 
pect. His behavioural episodes also began at 18 
months, but were mild and infrequent until he 
reached puberty at age 9. From age 9 to age 16, he 
would have four to five such episodes per year, 
prompting one or two psychiatric admissions per 
year related to these episodes with a variety of 
diagnoses, including bipolar disorder, schizoph- 
renia, depression, intermittent explosive disorder, 
organic hallucinosis, adjustment disorder with 
mixed disturbance of emotions and conduct, 
organic delusional syndrome, organic personality 
disorder, developmental disorder nos, anxiety 
disorder nos, panic disorder, other specified 
family circumstances, psychosis nos, and atten- 
tion deficit disorder with hyperactivity. His 
previous treatments included haloperidol, various 
other neuroleptics, phenytoin, imipramine, other 
tricyclics, lithium, and behavioural therapy, all 
without effect. Lithium and phenytoin were felt to 
have exacerbated his symptoms. 
His birth and developmental history are re- 
markable for a pregnancy complicated only by 
severe morning sickness and treated with Bened- 
ictin in the first trimester. He was the product of a 
full-term vaginal delivery with forceps, following 
21 hours of labour, and weighed 8 lb 8 oz. As an 
infant, he had frequent colic, difficulty feeding 
and cried excessively. He sat at 6 months, walked 
at 9 months, but had difficulty with fine motor 
skills. His language milestones were delayed, with 
four to five words at age 3; years, sentences at age 
6 years and difficulties with articulation. His 
receptive language was suspected as being prob- 
lematic as an infant and his hearing tested as 
normal at age 3. He was toilet trained for bowel at 
age 3 years 4 months and for bladder at 3 years 7 
months. He entered a specialized preschool at age 
3, and an outpatient rehabilitation school pro- 
gram at age 5, which he is still attending. He has 
had academic problems throughout his schooling 
especially in reading and in arithmetic. His 
behavioural problems, as discussed above, were 
prominent at school as well as at home. In 
between these discrete episodes, however, he 
otherwise has had very good relations with 
teachers and peers. He describes his childhood as 
being ‘happy’ despite the odour, seizures, and 
behavioural problems. The odour was present but 
was not a major problem until the age of 9. Of 
note is that he had an early onset of puberty at 
age 9, following his episode of chorea and 
coinciding with the exacerbation of his seizures 
and behavioural disturbances. 
His family history is remarkable for his mother, 
age 36, with ‘bleeding tendencies’, his oldest 
brother with learning difficulties requiring special 
reading classes, a half sister with a history of 
depression, a maternal second cousin with gene- 
ralized tonic-clonic seizures, a paternal aunt and 
uncle also with generalized tonic-clonic seizures, 
a maternal great grandfather with Sydenham’s 
chorea, a paternal grandfather with throat cancer, 
a paternal grandmother with Alzheimer’s, and 
multiple family members with a history of 
myocardial infarction. He is the oldest of four, 
with two brothers, ages 13 and 8 and one sister, 
age 4. He reports good relations with his siblings 
and parents. His father died at age 67 of a 
myocardial infarction when the patient was age 
12. 
Mental state examination 
On examination at admission, he appeared a 
pleasant, cooperative 16-year-old white male, 
casually dressed, appearing moderately anxious 
and agitated during the interview. He spoke with 
a marked dysarthria and a mild dysprosody; his 
rate of speech was slow. He was noted to be 
fidgeting throughout the interview, with some 
pacing, but had no evidence of a movement 
disorder. He appeared agitated and described 
feeling ‘down’ and irritable. He had no diurnal 
variation of his mood, and no thoughts of harm to 
himself or others. His sleep was markedly 
decreased, averaging 2 hours per night over the 2 
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weeks prior to presentation, and he had a 
decreased appetite with a 5 lb weight loss. He did, 
however, have a maintained interest in his 
hobbies over this time. There was no evidence of 
loosening of associations, thought insertion or 
withdrawal and no delusions or obsessions. He 
expressed concern over voices which he heard ‘as 
if’ they were coming from people inside him. He 
described hearing the voices of Luke Skywalker 
and Darth Vadar fighting inside him. The voice of 
Luke Skywalker was telling him to go home. He 
had no visual, olfactory, gustatory, or tactile 
hallucinations on admission but described pre- 
vious visual hallucinations (visions of devils) 
occurring during past episodes. He was alert and 
oriented and his attention was good, with digit 
recall intact, and serial 7s intact. He was able to 
recall two of three objects at 5 minutes and able 
to cite current and past presidents to Reagan. He 
demonstrated concrete proverb interpretation 
and was able to do simple arithmetic without 
difficulty, as well as to copy a circle and a square. 
He had reasonable insight, stating that he realized 
he was ill and commencing one of his ‘bad spells’ 
at the time of the interview. His neurological 
examination was intact. 
Investigations 
He had numerous blood and urine examinations, 
including LETS, TFTs, electrolytes, and FBS, as 
well as porphyria, organic acid and inborn error 
of metabolism screens which were all negative. 
He was karyotyped as a 46, XY normal male and 
his awake EEG showed medium voltage slow 
waves in the 4-6 HZ frequency seen indepen- 
dently from both temporal regions interictally. 
He also had telemetry showing spike and wave 
activity in both temporal regions. His CT scan 
and MRI scan were both normal. His urinary 
TMA level was elevated at 121 pg/ml (after 
choline challenge). ‘This confirmed the diagnosis 
of trimethylaminuria, and treatment with dietary 
restriction was begun at age 16. His performance 
Table 1: Patient’s performance on WISC at various ages, 
with those values at age 17 being done after one year of 
dietary restriction and as the Weschler Adult Intelligence 
Scale Revised (WAIS-R) 




Full scale IQ 
86 78 73 73 
96 82 70 80 
90 78 69 75 
on the Weschler Intelligence. Scale for Children 
(WISC) is shown in Table 1. 
Treatment course 
He has had an excellent response to dietary 
therapy with good adherence to a choline 
restricted diet. Since starting the diet 1 year ago, 
he has had only two brief episodes of seizures and 
behavioural disturbance each lasting several 
hours and a good response as well with respect to 
the odour. Both episodes were associated with 
identified dietary indiscretions preceding them. 
His seizures had been refractory to treatment 
prior to starting the diet, but are now well 
controlled on carbamazepine 400 mg tds. His 
response in terms of improvement in cognitive 
function is difficult to assess at this early stage. He 
does have some subjective improvement cogni- 
tively and has enrolled in a more academically 
oriented school program recently. His scores on 
the WAIS-R are encouraging but difficult to 
interpret as the scores cannot be directly com- 
pared to the WISC scores, without the results of 
the various sub-scales. 
DISCUSSION 
This is a 16-year-old white male with trimethyla- 
minuria presenting with episodes of a fish-like 
odour associated with complex-partial (cursive) 
seizures and a mixed affective state with and 
without auditory hallucinations and delusions. He 
responded well to treatment with dietary restric- 
tion of choline. This case represents the second 
case where seizures have been reported in 
trimethylaminuria and is one of several case 
reports on psychiatric disturbance associated with 
the disorder. The relationship of this patient’s 
seizures and behavioural disturbance to the 
development of the fish odour, occurring in 
discrete episodes, raises the possibility of these 
aspects of the illness being related to the defect in 
N-oxidation of trimethylamine, as opposed to 
being unrelated symptoms or related to a purely 
psychosocial reaction to the development of the 
odour itself. Certainly the latter explanation 
cannot be entirely excluded, with respect to his 
behavioural disturbance. However, the patient 
did not express any concern himself about the 
odour and the development of delusions and 
hallucinations would represent an unusual pre- 
sentation of such a reaction. The possibility of his 
behaviour being related to a postictal state was 
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also considered, but there was no clear temporal 
relation of the psychiatric disturbance to his 
seizures. 
Trimethylaminuria was first described clinically 
in 19705 and there have since been over 40 cases 
reported in the literature. The possession of a 
relatively inefficient form of flavin-containing 
monooxygenase (thought to be FM03)6, inher- 
ited in an autosomal recessive fashion, leads to 
the decreased metabolic conversion of dietary- 
derived odorous trimethylamine to the non- 
odorous trjmethylamine N-oxide. Excess tri- 
methylamine is consequently eliminated in the 
urine (trimethylaminuria), breath, sweat and 
other bodily secretions, thereby imparting a 
strong fish-like odour to the patient’. Clinical 
diagnosis may be confirmed by the finding of an 
increased urinary trimethylamine level and/or 
decreased trimethylamine N-oxide using gas- 
liquid chromatography either with or without a 
previous choline or trimethylamine challenge’V7*“. 
Treatment usually involves restricting the intake 
of dietary trimethylamine precursors (e.g. tri- 
methylamine N-oxide, choline) and the oc- 
casional use of antibiotics to decrease the 
bacterial liberation of trimethylamine from these 
precursors within the gut has also been 
suggested2. 
A similar disorder in chickens fed rapeseed 
meal has been linked to both genetic decrease in 
trimethylamine-N-oxidase and dietary intake of 
inhibitors of this enzyme: a tannin (polyphenolic) 
fraction and 5-vinyloxazolidine-2-thione (OZT) 
derived from progoitrin. Although not yet proven 
for humans with trimethylaminuria, avoidance of 
dietary OZT (high in the brassicas, pepper spice, 
horseradish) and tannins (high in teas and 
coffees) may also assist in odour reduction”. 
Trimethylaminuria has been associated in the 
literature with several congenital problems in- 
cluding Noonan’s (Ullrich’s) syndrome5, Prader- 
Willi syndrome”, onychodystrophy” and other 
situations such as hepatic’2*‘3 and renal 
disease’4*‘5 , viral infectionI and copper deficiency 
coupled with premature birth”. Nevertheless, 
several cases have been cited in otherwise healthy 
individuals with no associated clinical problems 
and it is now generally accepted that this odour 
production is a separate phenomenon and has 
been designated the ‘fish-odour syndrome’. 
However, in terms of neuropsychiatric aspects 
of trimethylaminuria, there is one case report 
which describes mental retardation and self- 
abusive behaviour” and another where seizures 
and encephalopathy were apparent, although 
these latter events were thought to be unrelated 
to the development of trimethylaminuria2. Seve- 
ral psychiatric disturbances have been reported in 
patients and these have been presumed to be 
psychosocial reactions to the odour. Feelings of 
shame, low self-esteem, social isolation, anxiety, 
depression, suicidal tendencies, paranoia, educa- 
tional and career disadvantages, relationship 
difficulties, addiction to alcohol and other drugs 
and overt aggression have all been described’,3.4. 
Speculation as to a causative linkage between 
neurological disorders and deficient trimethyla- 
mine N-oxidation could occur along several lines. 
Increased blood levels of trimethylamine, to- 
gether with other amines, are thought to play a 
role in the neurological dysfunction, en- 
cephalopathy and coma observed in hepatic and 
renal disease. Such elevated trimethylamine 
levels are found in patients with impaired 
hepatocellular function and in those possessing 
portosystemic shunts following treatment for 
cirrhosis, where the first-pass metabolism and 
consequent extraction of trimethylamine ab- 
sorbed from the gastrointestinal tract will be 
decreased’2*‘3. Similarly, in uraemic patients, the 
abnormal overgrowth of bacteria in the small 
intestine greatly increases the liberation of 
trimethylamine from dietary precursors and, 
compounded with reduced kidney function and 
subsequent decreased renal clearance, leads to 
elevated blood levels of this aminet4~“. Alterna- 
tively, the overproduction and accumulation or 
trimethylamine may be coincidental, reflecting an 
inefficiently functioning flavin-containing mono- 
oxygenase which may have other as yet unknown 
metabolic roles, perhaps within the brain itself. 
Secondary modulating influences such as steroid 
hormone levels’“, dietary enzyme inhibitors” or 
even trimethylamine itself as a competing sub- 
strate, may further suppress the already low 
enzyme activity, thereby precipitating problems. 
The effect of testosterone on N-oxidation’” may 
explain this patient’s exacerbation of symptoms at 
puberty. N-oxidation of TMA is likely 
polymorphic2’. The impairment of N-oxidation 
may, furthermore, be much more common than 
has been considered in the past, and the effects of 
such an impairment on other substances under- 
going N-oxidation (e.g. metapyrone, guanethi- 
dine, nicotine, nicotinamide, pinacidil) is not 
known20,2’. Further studies of the direct and 
indirect CNS effects of trimethylamine, the 
possible role of the flavin-containing monooxyge- 
nase system within the CNS and the clinical 
callsequences of its dysfunction as well as the 
effects of secondary modulating influences are 
needed. 
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CONCLUSION 
This case of a young boy with trimethylaminuria 
presenting with episodic seizures and behavioral 
disturbance temporally related to the develop- 
ment of the fish odour and responding to 
treatment with a choline-restricted diet raises 
some questions about the clinical spectrum of this 
disorder and the possible CNS effects of tri- 
methylamine. Seizures have been reported in one 
previous case of trimethylaminuria and psychiat- 
ric disturbance are relatively common in this 
disorder. Both have been assumed to be unre- 
lated to the pathogenesis of trimethylaminuria, 
however. This case suggests that not all of the 
psychiatric disturbances seen in this disorder are 
necessarily related to a psychosocial reaction to 
the odour itself. The temporal relationship of this 
patient’s seizures with his odour and the response 
to treatment also bring to question the possibility 
that neuropsychiatric manifestations can be re- 
lated to trimethylaminuria. In this context, it is 
interesting to note that in the early nineteenth 
century, odour was considered to be an important 
sign of psychiatric illness: “the breath of maniacal 
persons has been remarked by Esquirol and other 
practical authors to exhale a fetid smell, which 
some compare to that of stinking fish.“‘2 A 
multicentre study to look at the clinical spectrum 
of trimethylaminuria is currently underway. 
ACKNOWLEDGEMENTS 
The authors would like to thank Professor 
Fennessey, MS S. Tjoa and Dr T. Heads for their 
helpful comments on this manuscript as well as 
Dr E.H. Reynolds for his useful feedback on the 
initial presentation of this case at the 1996 
meeting of the British Branch of the ILAE. 
REFERENCES 
1. Ayesh, R., Mitchell, S.C., Zhang, A. and Smith, R.L. The 
fish odour syndrome: biochemical, familial, and clinical 
aspects. British Medical Journal 1993: 307: 655457. 
2. Danks, D.M., Hammond, J., and Schlesinger, P. 
Trimethylaminuria- diet does not always control the fishy 
odor. New England Journal of Medicine 1976: 295: 962. 


















plication of an adolescent with trimethylaminuria. Journal 
of Pediarrics 1979; 94: 936-937. 
Walker, V. The fish odour syndrome-the problems are 
psychosocial. British Medical Journal 1993; 307: 639. 
Humbert. J.R.. Hammond. K.B.. Hathaway. W.E.. 
Marcoux. J.G.. and Obrian. D. Trimethylaminuria- the 
fish odour syndrome. Lancer 1970: I: 770-l. 
Cashman, J.R. Structural and catalytic properties of the 
mammalian Ravin-containing monooxygenase, Chem. 
Rex Toxical. 1995: 8: 165-181. 
Brewster, M.A. and Schedewie, H. Trimethylaminuria. 
Annals of Clinical and Labortory Science 1983: 13: 20-24. 
Tjoa. S. and Fennessey, P. The identification of trimethyl- 
amine excess in man: quantitative analysis and biochemi- 
cal origins. Analyrical Biochemistry. 1991: 197: 77-82. 
Fenwick, G.R.. Butler, E.J. and Brewster. M.A. Are 
brassica vegetables aggravating factors in trimethylaminu- 
ria (fish odour syndrome)? Lancer 1983: 2: 916-917. 
Chen. H. and Aiello. F. Trimethylaminuria in a girl with 
Prader-Willi syndrome and del (15)(qllq13). American 
Journal of Medical Generics. 1993: 45: 335-339. 
Spellacy, E.. Watts. R.W.E. and Goolamali, S.K. Tri- 
methylaminuria. Journal of Inherited Metabolic Disease 
1979: 2: 85-88. 
Marks, R., Dudley. F. and Wan, A. Trimethylamine 
metabolism in liver disease. Lancer 1978: 1: 1106-l 107. 
Wranne, L. Urinary excretion of trimethylamine and 
trimethylamine oxide following trimethylamine ad- 
ministration to normals and patients with liver disease. 
Acra. Medica Scandanivica. 1956: 153: 433-441. 
Simenhoff. M.L.. Ginn, H.E. and Teschan, P.E. Toxicity 
of aliphatic amines in uremia. Transacrions of the Am. 
Sbc. Arti. Org. 1977: 23: 560-561. 
Wills, M.R. and Savory, J. Biochemistry of renal failure. 
Annals of Clinical and Laborarory Science. 1981: 11: 
292-299. 
Ruocco. V.. Fliorio. M., Grimaldi Filioli, F.. Guerrer, 
A.V. and Prota. G. An unusual case of trimethylaminuria. 
Brirish Journal Dermatology. 1989: 120: 459-461. 
Blumenthal, I.. Lealman. G.T. and Franklyn, P.P. 
Fracture of the femur, fish odour. and copper deficiency in 
a preterm infant. Archives of Disease in Childhood. 1980: 
55: 229-231. 
Shelley, E.D. and Shelley, W.B. The fish odour syndrome- 
trimethylaminuria. Journal of the American Medical 
Association 1984: 251(2): 253-255. 
Ayesh. R., Mitchell, SC. and Smith, R.L. Dysfunctional 
N-oxidation of trimethylamine and the influence of 
testosterone treatment in man. Pharmacogenedcs 1995; 5: 
244-246. 
Al-Waiz, M., Ayesh, R., Mitchell, S.C., Idle. J.R. and 
Smith, R.L. A genetic polymorphism of the N-oxidation 
of trimethylamine in humans. Clinical Pharmacology and 
Therapearics 1987: 42: 588-594. 
21. Hadidi, H.F., Cholerton, S., Atkinson, S., Irshaid, Y.M., 
Rawashdeh, N.M. and Idle, J.R. The N-oxidation of 
trimethylamine in a Jordanian population. British Journal 
of Clinical Pharmacology 1995: 39: 179-181. 
22. Man Burrows, G. Commentaries on insanity. In: Madness 
and Morals. Ideas on Insanity in the 19th Century (Ed. V. 
Skultanes). London: Rutlidge ans Keegan Paul, 1975: p. 
78. 
